
All posts by vmcimchiefs
Hypervirulent (Hypermucoviscous) Klebsiella – 09/06/2017 (Presented by guest lecturer Brian Sun, MD)







Calciphylaxis – 9/13/17
This is a RARE entity (only about 5% of ESRD patients) but has a HIGH mortality (60-80% in 1 year!)
Etiology: Abnormal deposition of calcium in the lumen of the arterial vasculature leading to compromised blood flow to the tissues and necrosis
Risk factors: Female sex, autoimmune disease, prednisone or coumadin use, elevated phosphorus levels, obesity, diabetes, and low albumin. Higher risk of development if you have a calcium x phosphorus level > 60-70.
Clinical presentation: Painful subcutaneous nodules with overlying red/brown patches and eventual central necrosis and eschars. Usually located in areas of high adipose tissue (thighs, abdomen, etc)
Treatment: Mostly supportive – have your patients eat a low phosphate diet and use non-calcium containing phosphate binders! (Remember, the calcium containing ones will cause more harm because it will still elevated your calcium x phosphate product!). Studies have shown some benefit to using sodium thiosulfate and hyperbaric oxygen but calciphylaxis cannot be cured.
Sickle Cell Acute Chest Syndrome – 09/12/2017










H Pylori – 09/07/2017 (presented by guest lecturer Tiffany Hsu, MD)











Hyponatremia – AM report 9/11/17

Pancreatitis – 09/05/2017













Malaria: Plasmodium Vivax – 08/29/2017






Choledocholithiasis – 08/23/2017





Digoxin Toxicity – 08/21/2017










